Giovanni Tafuri

Current state of quality of life and patient-reported outcomes research

Andrew Bottomley, Jaap C. Reijneveld, Michael Koller et al. · European Journal of Cancer · 2019 · 178 citations · Full text

Medicine, Health Policy, Oncology +17

Evaluation of Oncology Drugs at the European Medicines Agency and US Food and Drug Administration: When Differences Have an Impact on Clinical Practice

Francesco Trotta, Hubert G.M. Leufkens, Jan H.M. Schellens et al. · Journal of Clinical Oncology · 2011 · 78 citations

Medicine, Oncology, Pharmacology +10

Managing Risk and Uncertainty in Health Technology Introduction: The Role of Managed Entry Agreements

Panos Kanavos, Alessandra Ferrario, Giovanni Tafuri et al. · Global Policy · 2017 · 72 citations

Public Affairs, Health Care Management, Health Policy +12

How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice

Giovanni Tafuri, Margherita Pagnini, Jane Moseley et al. · British Journal of Clinical Pharmacology · 2016 · 64 citations · Full text

Public Affairs, Health Policy, Pharmaceutical Policy +14

Stopping a trial early in oncology: for patients or for industry?

Francesco Trotta, Giovanni Apolone, Silvio Garattini et al. · Annals of Oncology · 2008 · 52 citations · Full text

Medicine, Oncology, Clinical Trial Regulation +8